New Drug Shows Promise in Delaying Alzheimer’s Dementia
A new study from Washington University School of Medicine in St. Louis has found that the anti-amyloid drug lecanemab may delay the early stages of Alzheimer’s disease in people at high risk. What the Study Found Researchers tested lecanemab in people with early signs of Alzheimer’s but no dementia symptoms. These individuals had high levels […]